Skip to content
OpenAdvisories

Vendor

SOOIL Developments Co

0 known vulnerabilities.

SOOIL Developments Co at a glance

Last 12 months
0
Critical · all time
0
Exploited · all time
0
Public exploit · all time
0
New vulnerabilities per month · last 12 months
0 1 1 December 2025: 0 vulnerabilities Dec 2025 January 2026: 0 vulnerabilities February 2026: 0 vulnerabilities March 2026: 0 vulnerabilities Mar April 2026: 0 vulnerabilities May 2026: 0 vulnerabilities June 2026: 0 vulnerabilities Jun July 2026: 0 vulnerabilities August 2026: 0 vulnerabilities September 2026: 0 vulnerabilities Sep October 2026: 0 vulnerabilities November 2026: 0 vulnerabilities
Show as table
MonthVulnerabilitiesCritical
Nov 202600
Oct 202600
Sep 202600
Aug 202600
Jul 202600
Jun 202600
May 202600
Apr 202600
Mar 202600
Feb 202600
Jan 202600
Dec 202500
Nov 202500
Oct 202500
Sep 202500
Aug 202500
Jul 202500
Jun 202500
May 202500
Apr 202500
Mar 202500
Feb 202500
Jan 202500
Dec 202400

Products

AnyDana-A 0 Dana Diabecare RS 0 AnyDana-i 0

Latest advisories

  • High
    ICSMA-21-012-01 9 CVEs

    SOOIL Dana Diabecare RS Products

    Successful exploitation of these vulnerabilities could allow an attacker to access sensitive information, modify therapy settings, bypass authentication, or crash the device being accessed. These vulnerabilities could affect patient safety.

    SOOIL Developments Co
All Critical High Medium Low Exploited only Public exploit

0 results · Feed

Nothing found.